Skip to content

Author

A. El-kott

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

A PIEZO-Gated Mechanotransduction Timing Window Governs Scar Commitment in Wound Healing.

Cutaneous scarring remains a major clinical challenge, often resulting in impaired function, altered tissue mechanics, and poor aesthetic outcomes. Most current anti-fibrotic therapies target late-stage fibrosis, when extracellular matrix deposition and myofibroblast persistence are already established, limiting regene...

R. S. Hamad, Mohamed A. M. Ali, A. Chaudhary et al. · 0 citations
Review Sep 2026

The podocyte contactome in lupus nephritis: Current evidence and a framework for disease progression.

Lupus nephritis (LN) is initiated by immune-complex deposition, complement activation, and inflammation, but these mechanisms do not fully explain why some glomerular lesions resolve whereas others progress to podocyte depletion, glomerulosclerosis, and fibrosis. We present a conceptual spatial framework in which grade...

R. S. Hamad, Elsayed A. Elmorsy, A. El-kott et al. · 0 citations
Review Sep 2026

Biophysical and molecular mechanisms of lysosomal mechanoresilience: Membrane tension, TMEM63A, and cellular injury.

Lysosomal membrane failure contributes to cellular injury by disrupting degradation, metabolism, immune signaling, and compartmental integrity, yet the physical principles that determine whether a mechanically loaded lysosome adapts or ruptures remain incompletely resolved. This review integrates biophysical and molecu...

R. S. Hamad, A. El-kott, Sally Negm et al. · 0 citations
Review Open access Sep 2026

Carbon dots in cancer therapy: a novel approach to targeted drug delivery and reduced toxicity in gallbladder cancer

Biliary tract cancers (BTCs), including cholangiocarcinoma and gallbladder carcinoma, are highly aggressive malignancies associated with poor prognosis, late diagnosis, and limited therapeutic options. Conventional chemotherapy offers only modest survival benefits because of inadequate tumor selectivity, rapid systemic...

Mahvish Fatima, W. Parveen, Norah M. Almaneai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.